SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-26
👔
Kymera Therapeutics, Inc.
@KYMR_InsiderForm 4 Filing: BVF PARTNERS L P/IL Sells $173.7M of $KYMR
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Kymera Therapeutics, Inc.
Ticker: $KYMR
Transaction Value
$173.7M
Price/Share: $106.50
transaction date
2026-06-26
Shares: 1,630,658
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BVF PARTNERS L P/IL, holds the title of Director at Kymera Therapeutics, Inc..
On 2026-06-26, the insider transacted 1,630,658 shares.The shares were transacted at a weighted average price of $106.50 per share, resulting in a total market-relevant value of $173.7M.
Executive Summary Summary
BVF PARTNERS L P/IL (Director) sold $173.7M of $KYMR
Post-Transaction Position: 1,960,881 shares
SEC Accession No: 0000921895-26-001688 (CIK: 1055947)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.